首页> 美国卫生研究院文献>Endocrinology Diabetes Metabolism Case Reports >An FSH and TSH pituitary adenoma presenting with precocious puberty and central hyperthyroidism
【2h】

An FSH and TSH pituitary adenoma presenting with precocious puberty and central hyperthyroidism

机译:FSH和TSH垂体腺瘤表现为性早熟和中枢性甲状腺功能亢进

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A 19-year-old woman with a history of isosexual precocious puberty and bilateral oophorectomy at age 10 years because of giant ovarian cysts, presents with headaches and mild symptoms and signs of hyperthyroidism. Hormonal evaluation revealed elevated FSH and LH levels in the postmenopausal range and free hyperthyroxinemia with an inappropriately normal TSH. Pituitary MRI showed a 2-cm macroadenoma with suprasellar extension. She underwent successful surgical resection of the pituitary tumor, which proved to be composed of two distinct populations of cells, each of them strongly immunoreactive for FSH and TSH, respectively. This mixed adenoma resulted in two different hormonal hypersecretion syndromes: the first one during childhood and consisting of central precocious puberty and ovarian hyperstimulation due to the excessive secretion of biologically active FSH and which was not investigated in detail and 10 years later, central hyperthyroidism due to inappropriate secretion of biologically active TSH. Although infrequent, two cases of isosexual central precocious puberty in girls due to biologically active FSH secreted by a pituitary adenoma have been previously reported in the literature. However, this is the first reported case of a mixed adenoma capable of secreting both, biologically active FSH and TSH.Learning points: class="unordered" style="list-style-type:disc">Although functioning gonadotrophinomas are infrequent, they should be included in the differential diagnosis of isosexual central precocious puberty.Some functioning gonadotrophinomas are mixed adenomas, secreting other biologically active hormones besides FSH, such as TSH.Early recognition and appropriate treatment of these tumors by transsphenoidal surgery is crucial in order to avoid unnecessary therapeutic interventions that may irreversibly compromise gonadal function. class="head no_bottom_margin" id="__sec2title">BackgroundThe vast majority of nonfunctioning pituitary adenomas (NFPAs) are either diagnosed incidentally on imaging studies performed for unrelated reasons or present with symptoms and signs of mass effect such as headache and visual field abnormalities (, ). Over 50% of NFPA are of gonadotrope differentiation since they immunostain for βLH (luteinizing hormone), βFSH (follicle stimulating hormone) or α-subunit, as well as for SF-1 (steroidogenic factor-1), while they are non-reactive to Pit-1 (pituitary transcription factor 1) (). However, gonadotrophinomas seldom result in a hormonal hypersecretion syndrome because the peptides they synthesize are either not secreted or constitute hormone fragments devoid of biological activity (, ). A few of these gonadotrophinomas do secrete biologically active hormones, usually FSH, and are known as functioning gonadotrophin-producing adenomas (FGA) (). These FGA can result in isosexual central precocious puberty in children of both sexes, menstrual irregularities and ovarian hyperstimulation in premenopausal women and testicular enlargement in males ().We hereby present the case of a young woman with a history of isosexual, central precocious puberty during childhood, who 10 years later was found to have a mixed FSH- and TSH-producing adenoma resulting in central hyperthyroidism.
机译:一名19岁的妇女因巨大的卵巢囊肿而在10岁时患有等性性早熟和双侧卵巢切除术,表现出头痛,轻度症状和甲状腺功能亢进的迹象。激素评估显示,绝经后范围内FSH和LH水平升高,游离高甲状腺素血症,TSH异常正常。垂体MRI显示2厘米大的腺瘤,具有鞍上延伸。她成功地手术切除了垂体瘤,垂体瘤被证明由两个不同的细胞组成,每个细胞分别对FSH和TSH具有强烈的免疫反应性。这种混合性腺瘤导致两种不同的激素分泌过多综合征:第一种在儿童时期,由于中枢性性早熟和卵巢过度刺激(由于生物活性FSH的分泌过多)而引起,对此未作详细研究; 10年后,由于中枢性甲状腺功能亢进症生物活性TSH分泌不当。尽管很少见,但先前已在文献中报道了两例因垂体腺瘤分泌的具有生物活性的FSH而导致的女孩等位性中央性早熟。但是,这是首次报道的混合腺瘤能够同时分泌具有生物学活性的FSH和TSH的病例。学习要点: class =“ unordered” style =“ list-style-type:disc”> <!-list -behavior = unordered prefix-word = mark-type = disc max-label-size = 0-> 功能性促性腺激素瘤很少见,但应包括在等位性中央性早熟的鉴别诊断中。 一些功能性腺癌是混合性腺瘤,除了FSH外还分泌其他生物活性激素,例如TSH。 通过蝶窦手术及早识别和适当治疗这些肿瘤对于避免不必要的治疗干预至关重要。可能会不可逆地损害性腺功能。 class =“ head no_bottom_margin” id =“ __ sec2title”>背景绝大多数无功能垂体腺瘤(NFPA)都是在影像学研究中偶然诊断出的因不相关的原因执行或存在th的症状和体征的迹象,例如头痛和视野异常(,)。超过50%的NFPA具有促性腺激素分化作用,因为它们对βLH(促黄体激素),βFSH(促卵泡激素)或α亚基以及SF-1(类固醇生成因子-1)免疫,但它们没有反应性到Pit-1(垂体转录因子1)()。但是,促性腺激素缺乏症很少会导致激素分泌过多综合征,因为它们合成的肽要么不分泌,要么构成缺乏生物学活性的激素片段。其中一些促性腺激素确实分泌具有生物学活性的激素,通常是FSH,并且被称为功能性促性腺激素产生腺瘤(FGA)()。这些FGA可导致两性儿童的等位性中枢性早熟,绝经前的女性月经不调和卵巢过度刺激以及男性的睾丸增大()。十年后被发现患有混合性FSH和TSH的腺瘤,导致中央甲状腺功能亢进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号